These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19055230)

  • 1. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS; Bhatia MS
    PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
    Limpongsa E; Umprayn K
    AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
    Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
    Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions.
    Junyaprasert VB; Manwiwattanakul G
    Int J Pharm; 2008 Mar; 352(1-2):81-91. PubMed ID: 18061381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
    Loh ZC; Elkordy AA
    Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
    Rudraswamy-Math NR; Gupta VR
    Pak J Pharm Sci; 2015 Nov; 28(6):2147-52. PubMed ID: 26639508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
    Singh I; Saini V
    Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diltiazem Hydrochloride Floating Matrix Tablet: Formulation and
    Koradia KD; Jotaniya BK; Koradia HD
    Cardiovasc Hematol Disord Drug Targets; 2024; 24(2):110-124. PubMed ID: 39034726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design.
    Gohel MC; Panchal MK
    Drug Dev Ind Pharm; 2002 Jan; 28(1):77-87. PubMed ID: 11858527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.
    Patel A; Modasiya M; Shah D; Patel V
    AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.
    Gambhire MN; Ambade KW; Kurmi SD; Kadam VJ; Jadhav KR
    AAPS PharmSciTech; 2007 Sep; 8(3):E73. PubMed ID: 17915823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
    Kaialy W; Bello H; Asare-Addo K; Nokhodchi A
    J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
    Someshwar K; Chithaluru K; Ramarao T; Kumar KK
    Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divisability of diltiazem matrix sustained-release tablets.
    Costa P; Sousa Lobo JM
    Pharm Dev Technol; 2001 Aug; 6(3):343-51. PubMed ID: 11485176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.